Chemoinformaics analysis of RIBOTIDE-TRANS-ZEATIN
| Molecular Weight | 219.248 | nRot | 4 |
| Heavy Atom Molecular Weight | 206.144 | nRig | 12 |
| Exact Molecular Weight | 219.112 | nRing | 2 |
| Solubility: LogS | -2.511 | nHRing | 2 |
| Solubility: LogP | 0.605 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 5 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 10 |
| nHA | 5 | APOL | 31.6703 |
| nHD | 3 | BPOL | 17.6017 |
| QED | 0.641 |
| Synth | 3.932 |
| Natural Product Likeliness | 1.075 |
| NR-PPAR-gamma | 0.021 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.998 |
| HIA | 0.01 |
| CACO-2 | -4.927 |
| MDCK | 0.00000381 |
| BBB | 0.575 |
| PPB | 0.352637 |
| VDSS | 1.071 |
| FU | 0.705263 |
| CYP1A2-inh | 0.389 |
| CYP1A2-sub | 0.129 |
| CYP2c19-inh | 0.09 |
| CYP2c19-sub | 0.057 |
| CYP2c9-inh | 0.008 |
| CYP2c9-sub | 0.32 |
| CYP2d6-inh | 0.589 |
| CYP2d6-sub | 0.022 |
| CYP3a4-inh | 0.158 |
| CYP3a4-sub | 0.395 |
| CL | 9.85 |
| T12 | 0.943 |
| hERG | 0.026 |
| Ames | 0.016 |
| ROA | 0.985 |
| SkinSen | 0.943 |
| Carcinogencity | 0.019 |
| EI | 0.945 |
| Respiratory | 0.981 |
| NR-Aromatase | 0.873 |
| Antiviral | No |
| Prediction | 0.682361 |